Metoprolol Succinate
Product Images NDC 43353-016

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 43353-016). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 25mg (43353 0016 45)

Label for Metoprolol Succinate ER 25 mg, containing 45 tablets. The label shows the product name, strength (25 mg), dosage form (ER tablets), quantity (45 tablets), and the labeler Aphena Pharma Solutions - Tennessee, LLC. The label includes NDC 43353-0016-45 and repackaging information from Watson Laboratories, Inc., Corona, CA.*

FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Metoprolol Succinate Tablet Imprinted Symbol (Metoprolol Succinate Tablet Imprinted Symbol 04)

Metoprolol Succinate extended-release tablets, 25 mg, displayed in a blister pack. Each tablet is round, white, scored, and printed with the number '25'. The blister packaging shows multiple tablets arranged in two columns. No additional labeling or manufacturer information is visible on the pack itself.*

FDA Label Image

Metoprolol Succinate Tablet Imprinted Symbol (Metoprolol Succinate Tablet Imprinted Symbol)

Metoprolol Succinate extended-release tablets packaging showing the product name, strength 25 mg, and dosage form as tablets. The label includes the tablet count as 100 and displays the labeler as Aphena Pharma Solutions - Tennessee, LLC. The carton has a white background with blue and green design elements and the NDC 43353-016.*

FDA Label Image

Results For Subgroups In Merit-hf Graph (Results For Subgroups In Merit Hf Graph)

A forest plot titled 'Results for Subgroups in MERIT-HF' showing relative risk and 95% confidence intervals for total mortality, total mortality or all-cause hospitalization, and total mortality or hospitalization for heart failure across various subgroups such as geography, NYHA class, ejection fraction, ischemic etiology, sex, race, previous myocardial infarction, diabetes mellitus, hypertension status, and heart rate. Each subgroup comparison contrasts metoprolol succinate extended release tablets with placebo.*

FDA Label Image

Chemical Structure-metoprolol Succinate (Image 01)

Chemical structure of Metoprolol Succinate shown as a molecular diagram with labeled chemical groups representing the active ingredient in the product Metoprolol Succinate by Aphena Pharma Solutions - Tennessee, LLC.*

FDA Label Image

Watson Logo (Image 03)

Metoprolol Succinate 50 mg extended-release tablets in a clear plastic blister pack with a foil backing. The label printed on the foil shows the brand name, strength, and dosage form along with the manufacturer's name, Aphena Pharma Solutions - Tennessee, LLC. The blister holds ten tablets arranged in two rows of five.*

FDA Label Image

Watson Logo (Image 04)

Metoprolol Succinate extended-release tablets packaging label showing product name and the strength of 100 mg. The label includes the dosage form as extended-release tablets and the package count of 30 tablets. The labeler is Aphena Pharma Solutions - Tennessee, LLC. Additional details include storage instructions and a barcode on the front of the box.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.